ENLIVEN study: Pexidartinib for tenosynovial giant cell tumor (TGCT)

Tap, W

Tap, W (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.; Tap, W (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.

FUTURE ONCOLOGY, 2020; 16 (25): 1875

Abstract

Pexidartinib is the first approved medication in the USA for people with tenosynovial giant cell tumor (TGCT). The drug was approved based on the ENLI......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索